Skip to main content
SPARC - Logo
Innovations Inspired by life
Menu

Hamburger

  • Our Company
    • Who we are
    • History
    • Culture
    • Board of Directors
    • Leadership Team
  • OUR RESEARCH
    • Therapeutic focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline
  • Our Medicines
    • Xelpros®
    • Elepsia® XR
  • Business Development
    • Strategy
    • Partner with us
  • Investors
    • Who we are
    • Financials
    • Annual reports
    • Presentations
    • Chairman's Speech
    • Committees of BOD's
    • Shareholding pattern
    • Announcements & Disclosures
    • Policies & Codes
    • Listing Information
    • Board of Directors
    • FAQ’s
    • Investors Contact
    • Go green
    • IEPF
  • Media
    • Press Releases
    • Presentations
  • Careers
    • Overview
    • Apply Now
  • Contact Us
Our Research » Delivery Technologies

Pipeline Left Menu

  • Our Research
    • Therapeutic Focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline

Delivery Technologies

device-icon

Gastro Retentive Innovative Device (GRID™)

The GRID™ system provides predictive, reliable, sequential and combinatorial mechanis...

View Details
device-icon

Wrap Matrix™

It is a novel oral controlled drug delivery system based on pre-defined, precise and ...

View Details
device-icon

Abuse Deterrent Program

Non medical use of prescription opioids in USA has increased over threefold since 199...

View Details
device-icon

Nanotecton™ Technology

SPARC’s proprietary Nano-dispersion technology is based on forming a complex of drug ...

View Details
device-icon

Dry Powder Inhalation

Asthma affects over 334 million patients worldwide. Asthma and COPD is the third high...

View Details
device-icon

TearAct™

TearAct Technology consists of resin microparticle-complexed drug in a suspension for...

View Details
device-icon

Lipixelle™

LipixelleTM Technology is a platform for solubilizing ophthalmic drugs with limited w...

View Details
device-icon

Gel Free Reservoir(GFR™)

Chronic eye ailments like glaucoma typically require short-duration drugs to be insti...

View Details

Our Company

  • Who we are
  • history
  • Culture
  • board of directors
  • Leadership team

Our Research

  • Therapeutic focus
  • Delivery Technologies
  • Research Programs
  • R&D Pipeline

Investor Relations

  • Financials
  • Announcements & Disclosures
  • Shareholding pattern
  • Listing Information

Quick Links

Quick Links

  • Business Development
  • Investors
  • Media
  • Careers

Social Connect

  • twitter
  • linkedin

Employee Portal »

Copyright © 2019. Sun Pharma Advanced Research Company Ltd. All rights reserved.
Terms of Use  |   Archival Policy   |   Sitemap
Site Credits